Publications by authors named "Francesca Vanni"

Claim this Profile
A
A Novel Carbohydrate Fatty-Acid Monosulphate Ester, Squalane-in-Water Adjuvant Is Safe and Enhances Inactivated Influenza Vaccine Immunogenicity in Older Adults.
Valentino D'Onofrio, Bart Jacobs, Azhar Alhatemi, Simon De Gussem, Marjolein Verstraete, Francesca Vanni

Vaccines (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine targeting serogroups A, C, W, Y, and X when co-administered with routine childhood vaccines at ages 9 months and 15 months in Mali: a single-centre, double-blind, randomised, controlled, phase 3, non-inferiority trial.
Fatoumata Diallo, Fadima C Haidara, Milagritos D Tapia, Clara P Dominguez Islas, Mark R Alderson, Francesca Vanni

Lancet· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of a Carbohydrate Fatty Acid Monosulphate Ester Adjuvant Combined with a Low-Dose Quadrivalent Split-Virion Inactivated Influenza Vaccine: A Randomised, Observer-Blind, Active-Controlled, First-in-Human, Phase 1 Study.
Valentino D'Onofrio, Sharon Porrez, Bart Jacobs, Azhar Alhatemi, Fien De Boever, Francesca Vanni

Vaccines (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a double-color ELISpot assay of IFN-γ and IL-4 production in human peripheral blood mononuclear cells.
Francesca Dapporto, Domiziana De Tommaso, Camilla Marrocco, Pietro Piu, Claudia Semplici, Francesca Vanni

J Immunol Methods· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of multifunctional microtubule targeting agents endowed with dual pro-apoptotic and anti-autophagic efficacy.
Giuseppe Campiani, Tuhina Khan, Cristina Ulivieri, Leopoldo Staiano, Chiara Papulino, Francesca Vanni

Eur J Med Chem· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel class of oxazepine-based anti-cancer agents induces cell death in primary human CLL cells and efficiently reduces tumor growth in Eμ-TCL1 mice through the JNK/STAT4/p66Shc axis.
Francesca Vanni, Ludovica Lopresti, Vanessa Zurli, Anna Kabanova, Francesca Cattaneo

Pharmacol Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unravelling Atrioventricular Block Risk in Inflammatory Diseases: Systemic Inflammation Acutely Delays Atrioventricular Conduction via a Cytokine-Mediated Inhibition of Connexin43 Expression.
Pietro Enea Lazzerini, Maurizio Acampa, Michael Cupelli, Alessandra Gamberucci, Ujala Srivastava, Francesca Vanni

J Am Heart Assoc· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigation.
Nicola Relitti, A Prasanth Saraswati, Giulia Chemi, Margherita Brindisi, Simone Brogi, Francesca Vanni

Eur J Med Chem· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation.
A Prasanth Saraswati, Nicola Relitti, Margherita Brindisi, Jeremy D Osko, Giulia Chemi, Francesca Vanni

ACS Med Chem Lett· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Arrest Risk During Acute Infections: Systemic Inflammation Directly Prolongs QTc Interval via Cytokine-Mediated Effects on Potassium Channel Expression.
Pietro Enea Lazzerini, Maurizio Acampa, Franco Laghi-Pasini, Iacopo Bertolozzi, Francesco Finizola, Francesca Vanni

Circ Arrhythm Electrophysiol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-Amino-alkylated indoles: unexplored green products acting as anti-inflammatory agents.
Sarah Mazzotta, Luca Frattaruolo, Matteo Brindisi, Cristina Ulivieri, Francesca Vanni

Future Med Chem· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of a suturable biomimetic patch for cardiac applications.
Elisabetta Rosellini, Luigi Lazzeri, Simona Maltinti, Francesca Vanni, Niccoletta Barbani

J Mater Sci Mater Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6-Mediated Changes in Connexin Expression.
Pietro Enea Lazzerini, Franco Laghi-Pasini, Maurizio Acampa, Ujala Srivastava, Iacopo Bertolozzi, Francesca Vanni

J Am Heart Assoc· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes.
Pietro E Lazzerini, Iacopo Bertolozzi, Francesco Finizola, Maurizio Acampa, Mariarita Natale, Francesca Vanni

Front Pharmacol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes.
Pietro Enea Lazzerini, Franco Laghi-Pasini, Iacopo Bertolozzi, Gabriella Morozzi, Sauro Lorenzini, Francesca Vanni

Heart· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts.
Daniela Gentile, Pietro E Lazzerini, Alessandra Gamberucci, Mariarita Natale, Enrico Selvi, Francesca Vanni

Front Pharmacol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients.
Pierpaolo Pastina, Valerio Nardone, Stefania Croci, Giuseppe Battaglia, Francesca Vanni

J Thorac Dis· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis